15 Great Documentaries About Pragmatic Free Trial Meta: Difference between revisions

mNo edit summary
mNo edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
Pragmatic Free Trial Meta<br><br>Pragmatic Free Trial Meta is a free and non-commercial open data platform and infrastructure that supports research on pragmatic trials. It gathers and distributes clean trial data, ratings, and evaluations using PRECIS-2. This allows for diverse meta-epidemiological studies to evaluate the effects of treatment across trials of different levels of pragmatism.<br><br>Background<br><br>Pragmatic studies provide real-world evidence that can be used to make clinical decisions. However, the use of the term "pragmatic" is inconsistent and its definition and assessment requires clarification. Pragmatic trials should be designed to inform clinical practice and policy decisions, rather than confirm an hypothesis that is based on a clinical or physiological basis. A pragmatic study should strive to be as close as is possible to the real-world clinical practice,  [https://pageoftoday.com/story3644876/10-mobile-apps-that-are-the-best-for-pragmatic-kr 프라그마틱 정품확인] including recruiting participants, setting up, delivery and implementation of interventions, determination and analysis results, as well as primary analyses. This is a significant difference between explanatory trials as defined by Schwartz &amp; Lellouch1, which are designed to test a hypothesis in a more thorough manner.<br><br>Studies that are truly pragmatic should avoid attempting to blind participants or the clinicians, as this may result in distortions in estimates of the effect of treatment. The pragmatic trials also include patients from different health care settings to ensure that their outcomes can be compared to the real world.<br><br>Furthermore, trials that are pragmatic must be focused on outcomes that matter to patients, like quality of life and  [https://hotbookmarkings.com/story18330909/7-essential-tips-for-making-the-most-of-your-pragmatic-slot-buff 프라그마틱] functional recovery. This is especially important in trials that involve the use of invasive procedures or potentially serious adverse events. The CRASH trial29 compared a 2 page report with an electronic monitoring system for hospitalized patients with chronic cardiac failure. The catheter trial28 on the other hand, used symptomatic catheter associated urinary tract infection as the primary outcome.<br><br>In addition to these features, pragmatic trials should minimize the requirements for data collection and trial procedures to cut costs and time commitments. In the end the aim of pragmatic trials is to make their findings as applicable to current clinical practice as is possible. This can be accomplished by ensuring that their primary analysis is based on the intention-to treat approach (as described in CONSORT extensions).<br><br>Many RCTs that do not meet the criteria for pragmatism,  [https://bookmarklinx.com/ 슬롯] but have features that are contrary to pragmatism, have been published in journals of varying types and incorrectly labeled as pragmatic. This could lead to misleading claims of pragmaticity and the usage of the term needs to be standardized. The development of the PRECIS-2 tool, which provides a standard objective assessment of pragmatic features is a good initial step.<br><br>Methods<br><br>In a pragmatic research study the aim is to inform clinical or policy decisions by showing how an intervention can be integrated into routine treatment in real-world contexts. Explanatory trials test hypotheses regarding the cause-effect relationship within idealised settings. Therefore, pragmatic trials could have less internal validity than explanatory trials and might be more susceptible to bias in their design, conduct and analysis. Despite their limitations, pragmatic research can be a valuable source of information for decision-making within the healthcare context.<br><br>The PRECIS-2 tool evaluates the degree of pragmatism within an RCT by assessing it across 9 domains that range from 1 (very explicit) to 5 (very pragmatic). In this study, the recruitment, organisation, flexibility: delivery and follow-up domains received high scores, however, the primary outcome and the procedure for missing data were not at the pragmatic limit. This suggests that it is possible to design a trial with high-quality pragmatic features, without compromising the quality of its results.<br><br>However, it's difficult to determine how practical a particular trial really is because pragmatism is not a binary characteristic; certain aspects of a trial can be more pragmatic than others. The pragmatism of a trial can be affected by modifications to the protocol or logistics during the trial. Koppenaal and colleagues found that 36% of the 89 pragmatic studies were placebo-controlled or conducted prior to licensing. They also found that the majority were single-center. They are not close to the usual practice and are only considered pragmatic if their sponsors agree that the trials are not blinded.<br><br>A common aspect of pragmatic research is that researchers try to make their findings more relevant by studying subgroups within the trial sample. This can result in unbalanced analyses with less statistical power. This increases the chance of omitting or ignoring differences in the primary outcomes. This was the case in the meta-analysis of pragmatic trials due to the fact that secondary outcomes were not adjusted for covariates' differences at the baseline.<br><br>In addition, pragmatic studies may pose challenges to collection and interpretation of safety data. This is because adverse events are usually self-reported and are prone to reporting errors, delays or coding errors. It is therefore crucial to enhance the quality of outcomes assessment in these trials, ideally by using national registries instead of relying on participants to report adverse events on the trial's database.<br><br>Results<br><br>While the definition of pragmatism may not require that clinical trials be 100% pragmatist There are advantages of including pragmatic elements in trials. These include:<br><br>Incorporating routine patients, the results of the trial can be more quickly translated into clinical practice. However, pragmatic trials may have their disadvantages. The right type of heterogeneity, like could help a study extend its findings to different patients or settings. However, the wrong type can decrease the sensitivity of the test and thus lessen the power of a trial to detect minor treatment effects.<br><br>Numerous studies have attempted to categorize pragmatic trials using various definitions and scoring systems. Schwartz and Lellouch1 developed a framework to distinguish between research studies that prove a physiological or clinical hypothesis as well as pragmatic trials that help in the choice of appropriate therapies in clinical practice. The framework was composed of nine domains that were evaluated on a scale of 1-5, with 1 being more lucid while 5 being more pragmatic. The domains included recruitment, setting, intervention delivery and follow-up, as well as flexible adherence and primary analysis.<br><br>The original PRECIS tool3 was built on the same scale and domains. Koppenaal and colleagues10 developed an adaptation to this assessment, dubbed the Pragmascope that was simpler to use in systematic reviews. They found that pragmatic systematic reviews had higher average scores in the majority of domains, with lower scores in the primary analysis domain.<br><br>The difference in the primary analysis domains can be due to the way in which most pragmatic trials analyse data. Some explanatory trials, however do not. The overall score for pragmatic systematic reviews was lower when the areas of organisation, flexible delivery and follow-up were merged.<br><br>It is important to note that the term "pragmatic trial" does not necessarily mean a low quality trial, and indeed there is a growing number of clinical trials (as defined by MEDLINE search, however it is neither sensitive nor specific) that employ the term "pragmatic" in their abstracts or titles. The use of these words in abstracts and titles could suggest a greater awareness of the importance of pragmatism, however, it is not clear if this is manifested in the contents of the articles.<br><br>Conclusions<br><br>In recent times, pragmatic trials are increasing in popularity in research because the importance of real-world evidence is increasingly recognized. They are randomized trials that evaluate real-world care alternatives to new treatments that are being developed. They include patient populations that are more similar to those who receive treatment in regular medical care. This method has the potential to overcome the limitations of observational research that are prone to limitations of relying on volunteers, and the limited availability and the variability of coding in national registry systems.<br><br>Pragmatic trials also have advantages, including the ability to leverage existing data sources, and a greater likelihood of detecting meaningful differences from traditional trials. However, these tests could be prone to limitations that undermine their validity and generalizability. The participation rates in certain trials could be lower than expected because of the healthy-volunteering effect, financial incentives, or competition from other research studies. The requirement to recruit participants in a timely manner also limits the sample size and the impact of many pragmatic trials. In addition, some pragmatic trials lack controls to ensure that the observed differences are not due to biases in the conduct of trials.<br><br>The authors of the Pragmatic Free Trial Meta identified 48 RCTs that self-labeled themselves as pragmatic and were published from 2022. The PRECIS-2 tool was employed to evaluate the pragmatism of these trials. It includes areas such as eligibility criteria as well as recruitment flexibility as well as adherence to interventions and follow-up. They discovered that 14 of these trials scored as highly or pragmatic pragmatic (i.e., scoring 5 or more) in any one or more of these domains, and that the majority of them were single-center.<br><br>Trials with a high pragmatism score tend to have more expansive eligibility criteria than traditional RCTs that have specific criteria that are not likely to be present in the clinical setting, and contain patients from a broad variety of hospitals. The authors suggest that these characteristics can help make pragmatic trials more effective and  [https://seobookmarkpro.com/story18329829/why-you-should-concentrate-on-enhancing-pragmatic-free-game 프라그마틱 무료게임] 순위 ([https://bookmarkuse.com/story18143063/what-is-the-evolution-of-pragmatic-free https://bookmarkuse.com]) relevant to daily practice, but they don't necessarily mean that a pragmatic trial is free of bias. The pragmatism is not a definite characteristic; a pragmatic test that does not have all the characteristics of an explanatory study can still produce reliable and beneficial results.
Pragmatic Free Trial Meta<br><br>Pragmatic Free Trail Meta is an open data platform that allows research into pragmatic trials. It collects and distributes clean trial data, ratings and evaluations using PRECIS-2. This allows for diverse meta-epidemiological analyses that evaluate the effects of treatment across trials with different levels of pragmatism.<br><br>Background<br><br>Pragmatic trials are increasingly acknowledged as providing evidence from the real world for clinical decision making. However, the use of the term "pragmatic" is inconsistent and its definition as well as assessment requires further clarification. The purpose of pragmatic trials is to inform policy and clinical practice decisions, rather than confirm the validity of a clinical or physiological hypothesis. A pragmatic trial should aim to be as similar to real-world clinical practice as possible, including in its participation of participants,  [https://www.google.bs/url?q=https://pondgrain6.bravejournal.net/responsible-for-the-free-slot-pragmatic-budget 프라그마틱 정품확인] setting and design as well as the execution of the intervention, and the determination and analysis of outcomes and primary analyses. This is a major distinction from explanation trials (as described by Schwartz and Lellouch1) which are designed to provide more thorough proof of a hypothesis.<br><br>The most pragmatic trials should not be blind participants or the clinicians. This could lead to an overestimation of the effect of treatment. Practical trials should also aim to attract patients from a variety of health care settings so that their results are generalizable to the real world.<br><br>Furthermore, pragmatic trials should focus on outcomes that are important for patients, such as quality of life or functional recovery. This is especially important for trials that involve surgical procedures that are invasive or may have serious adverse effects. The CRASH trial29 compared a 2-page report with an electronic monitoring system for patients in hospitals suffering from chronic cardiac failure. The catheter trial28 on the other hand, used symptomatic catheter associated urinary tract infections as its primary outcome.<br><br>In addition to these aspects pragmatic trials should reduce the trial's procedures and data collection requirements in order to reduce costs. Furthermore pragmatic trials should strive to make their findings as applicable to clinical practice as is possible by making sure that their primary analysis is based on the intention-to-treat method (as described in CONSORT extensions for pragmatic trials).<br><br>Despite these requirements, many RCTs with features that defy the concept of pragmatism have been mislabeled as pragmatic and published in journals of all kinds. This could lead to misleading claims of pragmaticity and the usage of the term must be standardized. The development of a PRECIS-2 tool that offers an objective and standardized evaluation of the pragmatic characteristics is a good start.<br><br>Methods<br><br>In a pragmatic study the aim is to inform policy or clinical decisions by demonstrating how an intervention can be integrated into routine care in real-world settings. Explanatory trials test hypotheses about the causal-effect relationship in idealized environments. Therefore, pragmatic trials might have less internal validity than explanatory trials and might be more susceptible to bias in their design, conduct and analysis. Despite their limitations, [https://www.diggerslist.com/66ea7cce36c53/about 프라그마틱 슬롯] pragmatic research can be a valuable source of data for making decisions within the context of healthcare.<br><br>The PRECIS-2 tool scores an RCT on 9 domains, with scores ranging between 1 and 5 (very pragmatic). In this study, the recruitment, organisation, flexibility: delivery, flexible adherence and follow-up domains were awarded high scores, but the primary outcome and the method of missing data were below the practical limit. This indicates that a trial can be designed with good pragmatic features, without harming the quality of the trial.<br><br>It is difficult to determine the degree of pragmatism within a specific trial because pragmatism does not possess a specific attribute. Certain aspects of a study can be more pragmatic than other. Moreover, protocol or logistic changes during a trial can change its pragmatism score. Koppenaal and colleagues discovered that 36% of 89 pragmatic studies were placebo-controlled, or conducted prior to the licensing. Most were also single-center. Therefore, they aren't very close to usual practice and can only be described as pragmatic in the event that their sponsors are supportive of the lack of blinding in these trials.<br><br>A common aspect of pragmatic studies is that researchers try to make their findings more meaningful by analyzing subgroups of the trial sample. This can lead to unbalanced analyses that have less statistical power. This increases the risk of missing or misdetecting differences in the primary outcomes. This was a problem in the meta-analysis of pragmatic trials as secondary outcomes were not adjusted for covariates that differed at baseline.<br><br>In addition, pragmatic trials can also be a challenge in the collection and interpretation of safety data. This is because adverse events are generally reported by the participants themselves and prone to reporting errors, delays, or coding variations. It is essential to increase the accuracy and quality of the results in these trials.<br><br>Results<br><br>While the definition of pragmatism doesn't require that all clinical trials be 100% pragmatist, there are benefits of including pragmatic elements in trials. These include:<br><br>By incorporating routine patients, the results of trials are more easily translated into clinical practice. However, pragmatic trials may have their disadvantages. For instance, the right type of heterogeneity can help a trial to generalise its results to many different patients and settings; however the wrong kind of heterogeneity can reduce assay sensitiveness and consequently lessen the ability of a trial to detect minor treatment effects.<br><br>Numerous studies have attempted to categorize pragmatic trials, using various definitions and scoring systems. Schwartz and Lellouch1 developed an approach to distinguish between research studies that prove a clinical or physiological hypothesis, and pragmatic trials that inform the selection of appropriate treatments in real-world clinical practice. The framework was comprised of nine domains, each scoring on a scale ranging from 1 to 5, with 1 indicating more lucid and 5 indicating more practical. The domains covered recruitment of intervention, setting up, delivery of intervention, flexible compliance and primary analysis.<br><br>The initial PRECIS tool3 included similar domains and scales from 1 to 5. Koppenaal and colleagues10 created an adaptation of this assessment, called the Pragmascope, that was easier to use for systematic reviews. They found that pragmatic systematic reviews had a higher average score in most domains, but lower scores in the primary analysis domain.<br><br>This difference in the analysis domain that is primary could be explained by the fact that the majority of pragmatic trials analyse their data in the intention to treat manner however some explanation trials do not. The overall score for systematic reviews that were pragmatic was lower when the areas of organization, flexible delivery, and follow-up were merged.<br><br>It is important to understand that a pragmatic trial doesn't necessarily mean a low-quality trial, and in fact there is an increasing rate of clinical trials (as defined by MEDLINE search, however it is neither specific nor sensitive) which use the word "pragmatic" in their abstract or [https://www.google.co.cr/url?q=https://cherry-francis-2.thoughtlanes.net/10-pragmatic-slot-tips-tricks-all-pros-recommend 프라그마틱 슬롯 무료체험] 슬롯 환수율 ([http://wiki.iurium.cz/w/Wallmullins3544 http://Wiki.Iurium.cz/w/Wallmullins3544]) title. These terms could indicate a greater understanding of pragmatism in abstracts and titles, but it isn't clear if this is reflected in the content.<br><br>Conclusions<br><br>As the value of evidence from the real world becomes more popular and pragmatic trials have gained momentum in research. They are randomized trials that compare real world care alternatives to clinical trials in development. They are conducted with populations of patients more closely resembling those treated in regular medical care. This method can help overcome the limitations of observational research, [https://gm6699.com/home.php?mod=space&uid=3496753 프라그마틱 카지노] such as the limitations of relying on volunteers and the lack of availability and the variability of coding in national registry systems.<br><br>Pragmatic trials also have advantages, such as the ability to use existing data sources and a greater chance of detecting significant distinctions from traditional trials. However, they may still have limitations that undermine their credibility and generalizability. For  [https://vuf.minagricultura.gov.co/Lists/Informacin%20Servicios%20Web/DispForm.aspx?ID=9115929 프라그마틱 무료체험 슬롯버프] example the participation rates in certain trials might be lower than expected due to the healthy-volunteer effect and incentives to pay or compete for participants from other research studies (e.g., industry trials). The need to recruit individuals in a timely manner also restricts the sample size and impact of many pragmatic trials. Practical trials aren't always equipped with controls to ensure that observed differences aren't due to biases during the trial.<br><br>The authors of the Pragmatic Free Trial Meta identified RCTs published up to 2022 that self-described as pragmatism. They assessed pragmatism using the PRECIS-2 tool, which consists of the eligibility criteria for domains, recruitment, flexibility in adherence to intervention, and follow-up. They discovered that 14 of these trials scored pragmatic or highly pragmatic (i.e. scoring 5 or more) in any one or more of these domains and that the majority of them were single-center.<br><br>Studies with high pragmatism scores tend to have more lenient criteria for eligibility than traditional RCTs. They also include patients from a variety of hospitals. According to the authors, could make pragmatic trials more useful and useful in everyday clinical. However, they don't guarantee that a trial will be free of bias. The pragmatism characteristic is not a definite characteristic the test that does not have all the characteristics of an explicative study could still yield valid and useful outcomes.

Latest revision as of 12:06, 28 December 2024

Pragmatic Free Trial Meta

Pragmatic Free Trail Meta is an open data platform that allows research into pragmatic trials. It collects and distributes clean trial data, ratings and evaluations using PRECIS-2. This allows for diverse meta-epidemiological analyses that evaluate the effects of treatment across trials with different levels of pragmatism.

Background

Pragmatic trials are increasingly acknowledged as providing evidence from the real world for clinical decision making. However, the use of the term "pragmatic" is inconsistent and its definition as well as assessment requires further clarification. The purpose of pragmatic trials is to inform policy and clinical practice decisions, rather than confirm the validity of a clinical or physiological hypothesis. A pragmatic trial should aim to be as similar to real-world clinical practice as possible, including in its participation of participants, 프라그마틱 정품확인 setting and design as well as the execution of the intervention, and the determination and analysis of outcomes and primary analyses. This is a major distinction from explanation trials (as described by Schwartz and Lellouch1) which are designed to provide more thorough proof of a hypothesis.

The most pragmatic trials should not be blind participants or the clinicians. This could lead to an overestimation of the effect of treatment. Practical trials should also aim to attract patients from a variety of health care settings so that their results are generalizable to the real world.

Furthermore, pragmatic trials should focus on outcomes that are important for patients, such as quality of life or functional recovery. This is especially important for trials that involve surgical procedures that are invasive or may have serious adverse effects. The CRASH trial29 compared a 2-page report with an electronic monitoring system for patients in hospitals suffering from chronic cardiac failure. The catheter trial28 on the other hand, used symptomatic catheter associated urinary tract infections as its primary outcome.

In addition to these aspects pragmatic trials should reduce the trial's procedures and data collection requirements in order to reduce costs. Furthermore pragmatic trials should strive to make their findings as applicable to clinical practice as is possible by making sure that their primary analysis is based on the intention-to-treat method (as described in CONSORT extensions for pragmatic trials).

Despite these requirements, many RCTs with features that defy the concept of pragmatism have been mislabeled as pragmatic and published in journals of all kinds. This could lead to misleading claims of pragmaticity and the usage of the term must be standardized. The development of a PRECIS-2 tool that offers an objective and standardized evaluation of the pragmatic characteristics is a good start.

Methods

In a pragmatic study the aim is to inform policy or clinical decisions by demonstrating how an intervention can be integrated into routine care in real-world settings. Explanatory trials test hypotheses about the causal-effect relationship in idealized environments. Therefore, pragmatic trials might have less internal validity than explanatory trials and might be more susceptible to bias in their design, conduct and analysis. Despite their limitations, 프라그마틱 슬롯 pragmatic research can be a valuable source of data for making decisions within the context of healthcare.

The PRECIS-2 tool scores an RCT on 9 domains, with scores ranging between 1 and 5 (very pragmatic). In this study, the recruitment, organisation, flexibility: delivery, flexible adherence and follow-up domains were awarded high scores, but the primary outcome and the method of missing data were below the practical limit. This indicates that a trial can be designed with good pragmatic features, without harming the quality of the trial.

It is difficult to determine the degree of pragmatism within a specific trial because pragmatism does not possess a specific attribute. Certain aspects of a study can be more pragmatic than other. Moreover, protocol or logistic changes during a trial can change its pragmatism score. Koppenaal and colleagues discovered that 36% of 89 pragmatic studies were placebo-controlled, or conducted prior to the licensing. Most were also single-center. Therefore, they aren't very close to usual practice and can only be described as pragmatic in the event that their sponsors are supportive of the lack of blinding in these trials.

A common aspect of pragmatic studies is that researchers try to make their findings more meaningful by analyzing subgroups of the trial sample. This can lead to unbalanced analyses that have less statistical power. This increases the risk of missing or misdetecting differences in the primary outcomes. This was a problem in the meta-analysis of pragmatic trials as secondary outcomes were not adjusted for covariates that differed at baseline.

In addition, pragmatic trials can also be a challenge in the collection and interpretation of safety data. This is because adverse events are generally reported by the participants themselves and prone to reporting errors, delays, or coding variations. It is essential to increase the accuracy and quality of the results in these trials.

Results

While the definition of pragmatism doesn't require that all clinical trials be 100% pragmatist, there are benefits of including pragmatic elements in trials. These include:

By incorporating routine patients, the results of trials are more easily translated into clinical practice. However, pragmatic trials may have their disadvantages. For instance, the right type of heterogeneity can help a trial to generalise its results to many different patients and settings; however the wrong kind of heterogeneity can reduce assay sensitiveness and consequently lessen the ability of a trial to detect minor treatment effects.

Numerous studies have attempted to categorize pragmatic trials, using various definitions and scoring systems. Schwartz and Lellouch1 developed an approach to distinguish between research studies that prove a clinical or physiological hypothesis, and pragmatic trials that inform the selection of appropriate treatments in real-world clinical practice. The framework was comprised of nine domains, each scoring on a scale ranging from 1 to 5, with 1 indicating more lucid and 5 indicating more practical. The domains covered recruitment of intervention, setting up, delivery of intervention, flexible compliance and primary analysis.

The initial PRECIS tool3 included similar domains and scales from 1 to 5. Koppenaal and colleagues10 created an adaptation of this assessment, called the Pragmascope, that was easier to use for systematic reviews. They found that pragmatic systematic reviews had a higher average score in most domains, but lower scores in the primary analysis domain.

This difference in the analysis domain that is primary could be explained by the fact that the majority of pragmatic trials analyse their data in the intention to treat manner however some explanation trials do not. The overall score for systematic reviews that were pragmatic was lower when the areas of organization, flexible delivery, and follow-up were merged.

It is important to understand that a pragmatic trial doesn't necessarily mean a low-quality trial, and in fact there is an increasing rate of clinical trials (as defined by MEDLINE search, however it is neither specific nor sensitive) which use the word "pragmatic" in their abstract or 프라그마틱 슬롯 무료체험 슬롯 환수율 (http://Wiki.Iurium.cz/w/Wallmullins3544) title. These terms could indicate a greater understanding of pragmatism in abstracts and titles, but it isn't clear if this is reflected in the content.

Conclusions

As the value of evidence from the real world becomes more popular and pragmatic trials have gained momentum in research. They are randomized trials that compare real world care alternatives to clinical trials in development. They are conducted with populations of patients more closely resembling those treated in regular medical care. This method can help overcome the limitations of observational research, 프라그마틱 카지노 such as the limitations of relying on volunteers and the lack of availability and the variability of coding in national registry systems.

Pragmatic trials also have advantages, such as the ability to use existing data sources and a greater chance of detecting significant distinctions from traditional trials. However, they may still have limitations that undermine their credibility and generalizability. For 프라그마틱 무료체험 슬롯버프 example the participation rates in certain trials might be lower than expected due to the healthy-volunteer effect and incentives to pay or compete for participants from other research studies (e.g., industry trials). The need to recruit individuals in a timely manner also restricts the sample size and impact of many pragmatic trials. Practical trials aren't always equipped with controls to ensure that observed differences aren't due to biases during the trial.

The authors of the Pragmatic Free Trial Meta identified RCTs published up to 2022 that self-described as pragmatism. They assessed pragmatism using the PRECIS-2 tool, which consists of the eligibility criteria for domains, recruitment, flexibility in adherence to intervention, and follow-up. They discovered that 14 of these trials scored pragmatic or highly pragmatic (i.e. scoring 5 or more) in any one or more of these domains and that the majority of them were single-center.

Studies with high pragmatism scores tend to have more lenient criteria for eligibility than traditional RCTs. They also include patients from a variety of hospitals. According to the authors, could make pragmatic trials more useful and useful in everyday clinical. However, they don't guarantee that a trial will be free of bias. The pragmatism characteristic is not a definite characteristic the test that does not have all the characteristics of an explicative study could still yield valid and useful outcomes.